13F reference period
Q2 2026
Security Snapshot
Ascendis Pharma A/S - Ordinary Shares (ASND) Institutional Ownership
CUSIP: K08588103
13F Institutional Holders and Ownership History from Q1 2026 to Q3 2026
Institutions Reporting
304
Shares (Excl. Options)
66.36M
Full value: 66,359,512 · shares · 30 Jun 2026Price
$266.72
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares
- Symbol
- ASND on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 66,359,512
- Total 13F value
- $17,698,598,626
- Portfolio coverage rank
- 0.02%
- Share change
- +54,595,564
- Value change
- +$14,560,803,688
- Number of holders
- 304
- Shares outstanding
- 62,714,857
- SEC-reported price per share
- $227.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ASND - Ascendis Pharma A/S - Ordinary Shares is tracked under CUSIP K08588103.
- 304 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 8 to 304 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$1.82B
Full value: $1,815,328,317 · USD · 31 Mar 2026.$17.7B
Full value: $17,698,598,626 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 304 institutions filings for Q2 2026.
Security key
K08588103
13F reference period
Q2 2026
13F holders
304
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
ASND full holder history
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Ascendis Pharma A/S insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP K08588103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ASND
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Artisan Partners Limited Partnership | 4.2% | $698,595,845 | 2,634,024 | Artisan Partners Asset Management Inc. | 30 Jun 2026 |
As of 30 Jun 2026,
304
institutional investors reported holding
shares of
Ascendis Pharma A/S - Ordinary Shares (ASND).
This represents
106%
of the company’s total
outstanding shares.
66.36M
Full value: 66,359,512 · shares · 30 Jun 202662.71M
Full value: 62,714,857 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
89%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 16% | 10,281,496 | 24% | $2,742,280,613 | |
| T. Rowe Price Investment Management, Inc. | 11% | 6,754,846 | +9.6% | 1.2% | $1,801,653,000 |
| Avoro Capital Advisors LLC | 8.1% | 5,111,111 | 12% | $1,363,235,526 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7.7% | 4,798,267 | 4.2% | $1,279,793,795 | |
| Jupiter Topco LLC | 5.8% | 3,648,772 | 0% | 0.4% | $973,379,718 |
| FMR LLC | 5.7% | 3,545,575 | 0.04% | $945,675,893 | |
| Artisan Partners Limited Partnership | 4.2% | 2,634,024 | 1.1% | $702,546,942 | |
| BlackRock, Inc. | 3.5% | 2,211,833 | 0.01% | $589,940,098 | |
| Capital International Investors | 3.2% | 1,988,614 | 0.11% | $530,403,126 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3% | 1,875,301 | 0.17% | $500,141,116 | |
| FRANKLIN RESOURCES INC | 3% | 1,862,503 | 0.11% | $496,766,746 | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.5% | 1,548,636 | 0.07% | $413,052,195 | |
| AMERICAN CENTURY COMPANIES INC | 2.2% | 1,400,575 | 0.17% | $373,562,338 | |
| PERCEPTIVE ADVISORS LLC | 1.9% | 1,163,721 | 4.8% | $310,387,665 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.8% | 1,122,529 | -27% | 0.03% | $299,402,000 |
| Capital World Investors | 1.4% | 906,081 | 0.03% | $241,669,924 | |
| PRINCIPAL FINANCIAL GROUP INC | 1.4% | 873,502 | 0.11% | $232,980,454 | |
| Polar Capital Holdings Plc | 0.98% | 616,908 | 0.47% | $164,541,702 | |
| GOLDMAN SACHS GROUP INC | 0.89% | 559,534 | 0.02% | $149,238,909 | |
| MORGAN STANLEY | 0.87% | 544,393 | 0.01% | $145,200,813 | |
| STATE STREET CORP | 0.82% | 513,969 | 0% | $137,085,812 | |
| Invesco Ltd. | 0.66% | 414,196 | 0.01% | $110,474,356 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.64% | 403,151 | 0.01% | $107,528,433 | |
| UBS Group AG | 0.64% | 401,881 | 0.02% | $107,189,700 | |
| ALLIANCEBERNSTEIN L.P. | 0.64% | 399,292 | 0.04% | $106,499,162 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Headline period
Q2 2026
Rows shown
1-3 of 3